Zomepirac Sodium
- 24 July 1981
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA
- Vol. 246 (4) , 377-379
- https://doi.org/10.1001/jama.1981.03320040049033
Abstract
Zomepirac sodium (Zomax) is a new orally effective nonopioid analgesic that can relieve mild to severe pain. It is more effective than aspirin or codeine alone and is as effective as analgesic combinations containing codeine or other narcotics. Given orally, zomepirac has provided analgesia comparable with usual intramuscular doses of morphine in postoperative pain. With long-term use, neither tolerance to its analgesic effect nor psychic or physical dependence has been demonstrated. Like aspirin, zomepirac has anti-inflammatory and antipyretic actions and inhibits the synthesis of prostaglandins. Zomepirac is generally well tolerated with both short-term and long-term use; gastrointestinal reactions are the most frequently occurring side effects. (JAMA1981;246:377-379)Keywords
This publication has 5 references indexed in Scilit:
- Clinical Evaluation of Zomepirac and APC with Codeine in the Treatment of Postpartum Episiotomy PainThe Journal of Clinical Pharmacology, 1980
- Double‐Blind Comparisons of Zomepirac and Oxycodone with APC in Cancer PainThe Journal of Clinical Pharmacology, 1980
- Review of the Pharmacokinetics and Metabolism of Zomepirac in Man and AnimalsThe Journal of Clinical Pharmacology, 1980
- Analgesic Development: A Brief History and PerspectiveThe Journal of Clinical Pharmacology, 1980
- Efficacy of Zomepirac in Oral Surgical PainThe Journal of Clinical Pharmacology, 1980